Dr Ian Fotheringham, Managing Director and founder of Ingenza, has been awarded an MBE for services to Industrial Biotechnology in the Queen’s Birthday Honours List. This accolade recognises Ian’s position as a well-known industrial biotechnology expert. He originally gained extensive…
Ingenza’s ambitious SYNBIOPRO project for the development of biopharmaceuticals continues to make significant progress, despite the global disruption caused by the COVID-19 pandemic. Supported by a Scottish Enterprise research and development (R&D) grant since 2018, this project has hit a…
Ingenza has reached an important milestone in its work to develop a low cost recombinant human factor VIII (rhFVIII) production process to make materials for ProFactor Pharma Ltd (PFP). The goal of this work is to enable PFP to transform…
Edinburgh-based biotech company Ingenza Ltd. has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Ingenza has been working closely with researchers at Oxford University…
Edinburgh-based Ingenza, a leader in the application of biotechnology, has increased its footprint to over 12,000 sq ft within the Roslin Innovation Centre. This has allowed it to invest in additional bioprocessing equipment, supporting its upcoming project for the development…
Ingenza’s Dr Stephen McColm is celebrating success after being awarded a PhD in chemistry from the University of Edinburgh. Through an 1851 Royal Commission Fellowship, a scheme that funds innovative doctoral research with commercial potential, Stephen developed an enhanced DNA…
Amprologix, Executive Management team, Dr Gordon Barker, Professor Mathew Upton and Dr Ian Fotheringham. Ingenza is pleased to announce that University of Plymouth spin-out Amprologix, in which it has a stake, has been awarded a £1.2 million contract from the…
Ingenza is proud to announce that Managing Director Ian Fotheringham has been recognised with one of SCI Scotland’s most prestigious honours – the Charles Tennant Memorial Lecture award – acknowledging his expertise and knowledge in chemical research. SCI is a…
Ingenza, a leading industrial biotech company, is pleased to announce that Syngenta is exercising its commercial licensing option for a technology that enables the development of innovative crop protection products. This enabling technology – the result of an initial collaboration…
Ingenza colleague, Jack Kay, has been recognised by Life Sciences Scotland as their Rising Star for November 2018. Read more about Jack’s development and progression at Ingenza over the years on the Life Sciences Scotland website; https://www.lifesciencesscotland.com/rising-stars/novembers-rising-star-jack-kay